Upon intravenous administration in vivo in IBD models, this SOD/CAT-loaded nanocarrier significantly enhanced tissue regeneration and alleviated inflammation, outperforming single enzyme (SOD or CAT)-loaded nanocarriers and free mixtures of both enzymes without the nanocarrier [121]. This evidence concerns the gene CAT and inflammatory bowel disease.